Skip to main content

Advertisement

SpringerLink
Log in

Re-irradiation for salvage of prostate cancer failures after primary radiotherapy

  • Topic paper
  • Published:
World Journal of Urology Aims and scope Submit manuscript

Abstract

Purpose

To review the literature on use of radiation as a salvage option after local-only failure following initial treatment with radiation.

Methods

PubMed was searched from inception to June 2012 using terms designed to include relevant articles on salvage radiation as a treatment for local-only failures after radiation.

Results

Eighteen separate studies were found which demonstrated widely different patient populations, treatment methods, follow-up periods, and reporting. Only one phase II prospective study was found with no randomized controlled trials. Biochemical disease-free survival (bDFS) at four to 5 years ranged from 20 to 75 %. Patient selection may have influenced these varying rates since some studies with lower bDFS had higher risk populations. Factors associated with improved bDFS included post-treatment prostate-specific antigen (PSA) nadir of <0.5 ng/mL, pre-salvage PSA <6, Gleason score ≤7, and PSA doubling time (PSADT) >10 months. Overall survival ranged from 54 to 94 %, and disease-specific survival ranged from 74 to 100 %. The crude rate of grade 3–4 genitourinary toxicities among all studies was 13 % (range 0–47 %), and the crude rate of grade 3–4 gastrointestinal toxicities was 5 % (range 0–20 %). Incontinence rates were low among reviewed studies at 4 % (range 0–29 %).

Conclusions

Brachytherapy represents a reasonable salvage option for patients with local recurrence after initial radiotherapy for prostate cancer. However, rates of toxicities, as in other salvage treatments, can be fairly high, and the likelihood of death from prostate recurrence variable. Prospective studies are needed to better define the efficacy and toxicity of this treatment modality.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. American Cancer Society (2012) Cancer Facts & Figures 2012. http://www.cancer.org/acs/groups/content/@epidemiologysurveilance/documents/document/acspc-031941.pdf. Accessed 6/24/12

  2. Alicikus ZA, Yamada Y, Zhang Z, Pei X, Hunt M, Kollmeier M, Cox B, Zelefsky MJ (2011) Ten-year outcomes of high-dose, intensity-modulated radiotherapy for localized prostate cancer. Cancer 117(7):1429–1437. doi:10.1002/cncr.25467

    Article  PubMed  Google Scholar 

  3. Sylvester JE, Grimm PD, Wong J, Galbreath RW, Merrick G, Blasko JC (2011) Fifteen-year biochemical relapse-free survival, cause-specific survival, and overall survival following I(125) prostate brachytherapy in clinically localized prostate cancer: Seattle experience. Int J Radiat Oncol Biol Phys 81(2):376–381. doi:10.1016/j.ijrobp.2010.05.042

    Article  PubMed  Google Scholar 

  4. Kuban DA, Thames HD, Levy LB, Horwitz EM, Kupelian PA, Martinez AA, Michalski JM, Pisansky TM, Sandler HM, Shipley WU, Zelefsky MJ, Zietman AL (2003) Long-term multi-institutional analysis of stage T1–T2 prostate cancer treated with radiotherapy in the PSA era. Int J Radiat Oncol Biol Phys 57(4):915–928

    Article  PubMed  Google Scholar 

  5. Crook J, Borg J, Evans A, Toi A, Saibishkumar EP, Fung S, Ma C (2011) 10-year experience with I-125 prostate brachytherapy at the Princess Margaret Hospital: results for 1,100 patients. Int J Radiat Oncol Biol Phys 80(5):1323–1329. doi:10.1016/j.ijrobp.2010.04.038

    Article  PubMed  Google Scholar 

  6. Sylvester J, Grimm P, Blasko J, Meier R, Heaney C, Cavanaugh WA (2001) Transperineal permanent brachytherapy for local recurrence following external beam radiation for early-stage prostate cancer. J Brachytherapy Int 17:181–188

    Google Scholar 

  7. Freedland SJ, Humphreys EB, Mangold LA, Eisenberger M, Dorey FJ, Walsh PC, Partin AW (2007) Death in patients with recurrent prostate cancer after radical prostatectomy: prostate-specific antigen doubling time subgroups and their associated contributions to all-cause mortality. J Clin Oncol Off J Am Soc Clin Oncol 25(13):1765–1771. doi:10.1200/jco.2006.08.0572

    Article  Google Scholar 

  8. Leibovici D, Spiess PE, Heller L, Rodriguez-Bigas M, Chang G, Pisters LL (2008) Salvage surgery for locally recurrent prostate cancer after radiation therapy: tricks of the trade. Urol Oncol 26(1):9–16. doi:10.1016/j.urolonc.2006.12.016

    Article  PubMed  Google Scholar 

  9. Clarke HS Jr, Eskridge MR, El-Zawahry AM, Keane TE (2007) Salvage cryosurgical ablation of the prostate for local recurrence after radiation therapy: improved outcomes utilizing a capromab pendetide scan and biopsy algorithm. Can J Urol 14(Suppl 1):24–27

    PubMed  Google Scholar 

  10. Finley DS, Belldegrun AS (2011) Salvage cryotherapy for radiation-recurrent prostate cancer: outcomes and complications. Curr Urol Reports 12(3):209–215. doi:10.1007/s11934-011-0182-4

    Article  Google Scholar 

  11. Lukka H, Waldron T, Chin J, Mayhew L, Warde P, Winquist E, Rodrigues G, Shayegan B (2011) High-intensity focused ultrasound for prostate cancer: a systematic review. Clin Oncol (Royal College of Radiologists (Great Britain)) 23 (2):117–127 doi:10.1016/j.clon.2010.09.002

  12. Beyer DC (2003) Brachytherapy for recurrent prostate cancer after radiation therapy. Sem Rad Oncol 13(2):158–165. doi:10.1053/srao.2003.50015

    Article  Google Scholar 

  13. Nguyen PL, D’Amico AV, Lee AK, Suh WW (2007) Patient selection, cancer control, and complications after salvage local therapy for postradiation prostate-specific antigen failure: a systematic review of the literature. Cancer 110(7):1417–1428. doi:10.1002/cncr.22941

    Article  PubMed  Google Scholar 

  14. Mottet N, Bellmunt J, Bolla M, Joniau S, Mason M, Matveev V, Schmid HP, Van der Kwast T, Wiegel T, Zattoni F, Heidenreich A (2011) EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancer. Eur Urol 59(4):572–583. doi:10.1016/j.eururo.2011.01.025

    Article  PubMed  Google Scholar 

  15. Abouassaly R, Paciorek A, Ryan CJ, Carroll PR, Klein EA (2009) Predictors of clinical metastasis in prostate cancer patients receiving androgen deprivation therapy: results from CaPSURE. Cancer 115(19):4470–4476. doi:10.1002/cncr.24526

    Article  PubMed  Google Scholar 

  16. Crook JM, Choan E, Perry GA, Robertson S, Esche BA (1998) Serum prostate-specific antigen profile following radiotherapy for prostate cancer: implications for patterns of failure and definition of cure. Urology 51(4):566–572

    Article  PubMed  CAS  Google Scholar 

  17. Aaronson DS, Yamasaki I, Gottschalk A, Speight J, Hsu IC, Pickett B, Roach M 3rd, Shinohara K (2009) Salvage permanent perineal radioactive-seed implantation for treating recurrence of localized prostate adenocarcinoma after external beam radiotherapy. BJU Int 104(5):600–604. doi:10.1111/j.1464-410X.2009.08445.x

    Article  PubMed  Google Scholar 

  18. Allen GW, Howard AR, Jarrard DF, Ritter MA (2007) Management of prostate cancer recurrences after radiation therapy-brachytherapy as a salvage option. Cancer 110(7):1405–1416. doi:10.1002/cncr.22940

    Article  PubMed  Google Scholar 

  19. Beyer DC (1999) Permanent brachytherapy as salvage treatment for recurrent prostate cancer. Urology 54(5):880–883

    Article  PubMed  CAS  Google Scholar 

  20. Burri RJ, Stone NN, Unger P, Stock RG (2010) Long-term outcome and toxicity of salvage brachytherapy for local failure after initial radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 77(5):1338–1344. doi:10.1016/j.ijrobp.2009.06.061

    Article  PubMed  Google Scholar 

  21. Cumes DM, Goffinet DR, Martinez A, Stamey TA (1981) Complication of 125 iodine implantation and pelvic lymphadenectomy for prostatic cancer with special reference to patients who had failed external beam therapy as their initial mode of therapy. J Urol 126(5):620–622

    PubMed  CAS  Google Scholar 

  22. Dattoli M, Cash J, Ross R, Geohagen B, Palm J, Koval J, Sorace R (1997) Neoadjuvant hormone therapy and palladium-103 brachytherapy as salvage for locally recurrent prostate cancer. Proc Am Soc Clin Oncol 16:1118. (Abstract)

    Google Scholar 

  23. Grado GL, Collins JM, Kriegshauser JS, Balch CS, Grado MM, Swanson GP, Larson TR, Wilkes MM, Navickis RJ (1999) Salvage brachytherapy for localized prostate cancer after radiotherapy failure. Urology 53(1):2–10

    Article  PubMed  CAS  Google Scholar 

  24. Jo Y, Fujii T, Hara R, Yokoyama T, Miyaji Y, Yoden E, Hiratsuka J, Nagai A (2012) Salvage high-dose-rate brachytherapy for local prostate cancer recurrence after radiotherapy: preliminary results. BJU Int 109(6):835–839. doi:10.1111/j.1464-410X.2011.10519.x

    Article  PubMed  Google Scholar 

  25. Koutrouvelis P, Hendricks F, Lailas N, Gil-Montero G, Sehn J, Khawand N, Bondy H, Katz S (2003) Salvage reimplantation in patient with local recurrent prostate carcinoma after brachytherapy with three dimensional computed tomography-guided permanent pararectal implant. Technol Cancer Res Treat 2(4):339–344

    PubMed  Google Scholar 

  26. Lee B, Shinohara K, Weinberg V, Gottschalk AR, Pouliot J, Roach M 3rd, Hsu IC (2007) Feasibility of high-dose-rate brachytherapy salvage for local prostate cancer recurrence after radiotherapy: the University of California-San Francisco experience. Int J Radiat Oncol Biol Phys 67(4):1106–1112. doi:10.1016/j.ijrobp.2006.10.012

    Article  PubMed  Google Scholar 

  27. Lee HK, Adams MT, Motta J (2008) Salvage prostate brachytherapy for localized prostate cancer failure after external beam radiation therapy. Brachytherapy 7(1):17–21. doi:10.1016/j.brachy.2007.11.002

    Article  PubMed  Google Scholar 

  28. Loening SA, Turner JW (1993) Use of percutaneous transperineal 198Au seeds to treat recurrent prostate adenocarcinoma after failure of definitive radiotherapy. Prostate 23(4):283–290

    Article  PubMed  CAS  Google Scholar 

  29. Moman MR, van der Poel HG, Battermann JJ, Moerland MA, van Vulpen M (2010) Treatment outcome and toxicity after salvage 125-I implantation for prostate cancer recurrences after primary 125-I implantation and external beam radiotherapy. Brachytherapy 9(2):119–125. doi:10.1016/j.brachy.2009.06.007

    Article  PubMed  Google Scholar 

  30. Nguyen PL, Chen MH, D’Amico AV, Tempany CM, Steele GS, Albert M, Cormack RA, Carr-Locke DL, Bleday R, Suh WW (2007) Magnetic resonance image-guided salvage brachytherapy after radiation in select men who initially presented with favorable-risk prostate cancer: a prospective phase 2 study. Cancer 110(7):1485–1492. doi:10.1002/cncr.22934

    Article  PubMed  Google Scholar 

  31. Teh BS, Berner BM, Carpenter LS, Chiu JK, Dennis WS, Lu HH, Woo SY, Butler EB (1998) Permanent Gold-198 Implant for locally recurrent adenocarcinoma of the prostate after failing initial radiotherapy. J Brachytherapy Int 14:233–240

    Google Scholar 

  32. Tharp M, Hardacre M, Bennett R, Jones WT, Stuhldreher D, Vaught J (2008) Prostate high-dose-rate brachytherapy as salvage treatment of local failure after previous external or permanent seed irradiation for prostate cancer. Brachytherapy 7(3):231–236. doi:10.1016/j.brachy.2008.03.003

    Article  PubMed  Google Scholar 

  33. Wallner KE, Nori D, Morse MJ, Sogani PC, Whitmore WF, Fuks Z (1990) 125iodine reimplantation for locally progressive prostatic carcinoma. J Urol 144(3):704–706

    PubMed  CAS  Google Scholar 

  34. Wong WW, Buskirk SJ, Schild SE, Prussak KA, Davis BJ (2006) Combined prostate brachytherapy and short-term androgen deprivation therapy as salvage therapy for locally recurrent prostate cancer after external beam irradiation. J Urol 176(5):2020–2024. doi:10.1016/j.juro.2006.07.008

    Article  PubMed  Google Scholar 

  35. Butler EB, Scardino PT, Teh BS, Uhl BM, Guerriero WG, Carlton CE, Berner BM, Dennis WS, Carpenter LS, Lu HH, Chiu JK, Kent TS, Woo SY (1997) The Baylor College of Medicine experience with gold seed implantation. Semin Surg Oncol 13(6):406–418

    Article  PubMed  CAS  Google Scholar 

Download references

Conflict of interest

The authors declare there are no conflicts of interest associated with this manuscript. Potential conflicts of interest do exist and include the fact that Dr. Marshall is paid by C.R. Bard, Inc. to develop and administer educational programs on prostate brachytherapy.

Author information

Authors and Affiliations

  1. Department of Radiation Oncology, Hollings Cancer Center, Medical University of South Carolina, MSC 318, 169 Ashley Avenue, Charleston, SC, 29425, USA

    Stephen J. Ramey & David T. Marshall

Authors
  1. Stephen J. Ramey
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. David T. Marshall
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to David T. Marshall.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ramey, S.J., Marshall, D.T. Re-irradiation for salvage of prostate cancer failures after primary radiotherapy. World J Urol 31, 1339–1345 (2013). https://doi.org/10.1007/s00345-012-0953-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00345-012-0953-7

Keywords

Search

Navigation